Pfizer Inc.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
Pfizer-Upjohn seeks to support innovative outreach programs for patients with early signs of up to two chronic conditions (such as hypertension or depression) who are middle aged (35-64 years of age) and/or older adults (age 65 years and up). Programs would aim to better understand how to engage these individuals in ongoing patient care.
Programs should focus on or involve primary health care providers, pharmacists, nurses, community/office staff personnel or health systems.
Grant Application due date: November 25, 2019